Home > Press > NanoInk Announces Joint Research & Licensing Agreements with Prestigious Universities
Abstract:
NanoInk to collaborate with the UK Centre for Tissue Engineering at the University of Liverpool and the Centre of Molecular NanoMetrology at the University of Strathclyde
NanoInk's NanoStem Cell Division announced today it has entered into joint research and licensing agreements with the UK Centre for Tissue Engineering (UKCTE) at the University of Liverpool in Liverpool, England, and the Centre of Molecular NanoMetrology at the University of Strathclyde in Glasgow, Scotland, for the development of modified surfaces for manipulation of stem cell differentiation. Dr. John Hunt at the UKCTE at the University of Liverpool and Dr. Duncan Graham at the Centre of Molecular NanoMetrology at the University of Strathclyde will act as principal investigators for the collaboration.
"We are extremely excited to join forces with these two esteemed institutions," said Jim Hussey, chief executive officer of NanoInk. "We are eager to pursue the commercial potential of using nanotechnology to control stem cell function, particularly in the area of regenerative medicine. Each organization brings a distinct area of expertise to the process and it is our hope that the knowledge we obtain through our collaborative approach will propel our stem cell application and capabilities in the area of regenerative medicine."
In January 2009, NanoInk launched the NanoStem Cell Division, which is aimed at providing a highly reliable, renewable source of differentiated adult stem cells. Leveraging NanoInk's proprietary Dip Pen Nanolithography® (DPN®) technology, it is now possible to produce differentiated homogenous stem cell populations which will lead to faster and more efficient drug discovery and development processes, with substantial cost savings. For more information about the NanoStem Cell Division, see www.nanoink.net/NanoStem_about.htm.
####
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.
NanoInk, the NanoInk logo, Dip Pen Nanolithography and DPN are trademarks or registered trademarks of NanoInk, Inc.
For more information, please click here
Contacts:
David Gutierrez
Dresner Corporate Services
312-780-7204
Jennifer Jameson
Dresner Corporate Services
312-780-7241
Copyright © NanoInk
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||